Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilie Bernichon

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Journal of Neuropathology and Experimental Neurology|August 10, 2020
Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor ProgressionPierre Dal Col, Delphine Poncet, Romain Rivoirard, et al.
Bulletin Du Cancer|December 28, 2020
Predictive resistance factors in lung cancer patients treated with Nivolumab. Retrospective studyEmilie Bernichon, Claire Tissot, Sophie Bayle-Bleuez, et al.
Presse Medicale (Paris, France : 1983)|July 17, 2019
[HPV: Carcinogenic implications and preventive measures]Emilie Bernichon, Sophie Espenel, Benoite Méry, et al.
Critical Reviews in Oncology/Hematology|October 9, 2018
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategiesMing Yuan He, Chloé Rancoule, Amel Rehailia-Blanchard, et al.
Bulletin Du Cancer|October 5, 2019
Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past yearsEdouard Chanal, Wafa Bouleftour, Aline Guillot, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Journal of Neuropathology and Experimental Neurology|August 10, 2020
Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor ProgressionPierre Dal Col, Delphine Poncet, Romain Rivoirard, et al.
Bulletin Du Cancer|December 28, 2020
Predictive resistance factors in lung cancer patients treated with Nivolumab. Retrospective studyEmilie Bernichon, Claire Tissot, Sophie Bayle-Bleuez, et al.
Presse Medicale (Paris, France : 1983)|July 17, 2019
[HPV: Carcinogenic implications and preventive measures]Emilie Bernichon, Sophie Espenel, Benoite Méry, et al.
Critical Reviews in Oncology/Hematology|October 9, 2018
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategiesMing Yuan He, Chloé Rancoule, Amel Rehailia-Blanchard, et al.
Bulletin Du Cancer|October 5, 2019
Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past yearsEdouard Chanal, Wafa Bouleftour, Aline Guillot, et al.
Pageof 1